Axonal Regeneration through Regions of Chondroitin Sulfate Proteoglycan Deposition after Spinal Cord Injury: A Balance of Permissiveness and Inhibition

作者: Leonard L. Jones , Dana Sajed , Mark H. Tuszynski

DOI: 10.1523/JNEUROSCI.23-28-09276.2003

关键词: BrevicanExtracellular matrixNeurocanGrowth factorCell biologyBiologySciatic nerve injuryNeuroscienceVersicanChondroitin sulfate proteoglycanNeurite

摘要: Increased expression of certain extracellular matrix (ECM) molecules after CNS injury is believed to restrict axonal regeneration. The chondroitin sulfate proteoglycans (CSPGs) are one such class ECM that inhibit neurite outgrowth in vitro and upregulated injury. We examined growth responses several classes axons this inhibitory environment the presence a cellular fibroblast bridge spinal cord lesion site factor stimulus at (fibroblasts genetically modified secrete NGF). Immunohistochemical analysis showed dense labeling CSPGs NG2, brevican, neurocan, versican, phosphacan host-lesion interface (SCI). Furthermore, robust lesser extent was also observed throughout grafts control NGF-secreting fibroblasts. Despite milieu, penetrated grafts, including dorsal column sensory, rubrospinal, nociceptive axons. Axon amplified more grafts. Confocal microscopy demonstrated axon was, paradoxically, preferentially associated with NG2-rich substrates both graft types. NG2 increased sciatic nerve injury, wherein successfully regenerate. Cellular sources SCI peripheral sites included Schwann cells endothelial cells. Notably, these same produced cell adhesion L1 laminin, all colocalized. Thus, grow along coexpressing permissive molecules, suggesting regeneration successful when local signals balance exceed signals.

参考文章(76)
Clifford J Woolf, No Nogo: Now Where to Go? Neuron. ,vol. 38, pp. 153- 156 ,(2003) , 10.1016/S0896-6273(03)00233-2
Martin Grumet, David R. Friedlander, Takeshi Sakurai, Functions of brain chondroitin sulfate proteoglycans during developments: interactions with adhesion molecules. Perspectives on developmental neurobiology. ,vol. 3, pp. 319- 330 ,(1996)
Armin Blesch, Ray J. Grill, Mark H. Tuszynski, Chapter 32 Neurotrophin gene therapy in CNS models of trauma and degeneration Progress in Brain Research. ,vol. 117, pp. 473- 484 ,(1998) , 10.1016/S0079-6123(08)64033-9
Hidekazu Yamada, Barbara Fredette, Kenya Shitara, Kazuki Hagihara, Ryu Miura, Barbara Ranscht, William B. Stallcup, Yu Yamaguchi, The Brain Chondroitin Sulfate Proteoglycan Brevican Associates with Astrocytes Ensheathing Cerebellar Glomeruli and Inhibits Neurite Outgrowth from Granule Neurons The Journal of Neuroscience. ,vol. 17, pp. 7784- 7795 ,(1997) , 10.1523/JNEUROSCI.17-20-07784.1997
D.R. Zimmermann, E. Ruoslahti, Multiple domains of the large fibroblast proteoglycan, versican. The EMBO Journal. ,vol. 8, pp. 2975- 2981 ,(1989) , 10.1002/J.1460-2075.1989.TB08447.X
A.Dusty Miller, Daniel G. Miller, J. Victor Garcia, Carmel M. Lynch, Use of retroviral vectors for gene transfer and expression. Methods in Enzymology. ,vol. 217, pp. 581- 599 ,(1993) , 10.1016/0076-6879(93)17090-R
Stephen J. A. Davies, Michael T. Fitch, Stacey P. Memberg, Alison K. Hall, Geoffrey Raisman, Jerry Silver, Regeneration of adult axons in white matter tracts of the central nervous system Nature. ,vol. 390, pp. 680- 683 ,(1997) , 10.1038/37776
R. Grill, K. Murai, A. Blesch, F. H. Gage, M. H. Tuszynski, Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury The Journal of Neuroscience. ,vol. 17, pp. 5560- 5572 ,(1997) , 10.1523/JNEUROSCI.17-14-05560.1997
CL Dou, JM Levine, Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan The Journal of Neuroscience. ,vol. 14, pp. 7616- 7628 ,(1994) , 10.1523/JNEUROSCI.14-12-07616.1994
Richard A. Asher, Daniel A. Morgenstern, Morven C. Shearer, Kathryn H. Adcock, Penka Pesheva, James W. Fawcett, Versican Is Upregulated in CNS Injury and Is a Product of Oligodendrocyte Lineage Cells The Journal of Neuroscience. ,vol. 22, pp. 2225- 2236 ,(2002) , 10.1523/JNEUROSCI.22-06-02225.2002